Company / Depreciation & Amortization
RAPT Therapeutics, Inc. Depreciation & Amortization History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$1.2M
FY2024
5-year range
$996.0K / $1.2M
FY2020-FY2024
Trend
-1.1%
vs FY2023
Sector context
#137 of 192
Health Care
What the data says
At $1M, RAPT Therapeutics, Inc.'s depreciation & amortization ranks #56 of 192 in the Health Care sector. Depreciation & Amortization has fluctuated over the past 7 years, ranging from $996,000 in FY2021 to $1M in FY2019.
Based on SEC 10-K filings.
$1M in FY2024 with a 5-year CAGR of -2.0%.
Increased from $1M to $1M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +6.5%
- 5-Year CAGR
- -2.0%
- 10-Year CAGR
- -
Sector benchmark
#56 of 192 in Health CareTop 29% of 192This company $1.2M Sector average $188.2M
▼
-99.4% below sector average
Key checks
Key Insights
- 5-year CAGR of -2.0%, indicating a declining trend.
- In FY2024, depreciation & amortization decreased 1.1% year-over-year.
- Ranks #137 out of 192 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.38 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.2M | -1.1% |
| FY2023 | $1.2M | +16.1% |
| FY2022 | $1.0M | +5.1% |
| FY2021 | $996.0K | -11.3% |
| FY2020 | $1.1M | -15.6% |
| FY2019 | $1.3M | +7.5% |
| FY2018 | $1.2M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026